Skip to main content

Table 3 Network meta-analysis, lung cancer mortality results

From: Do we know enough about the effect of low-dose computed tomography screening for lung cancer on mortality to act? An updated systematic review, meta-analysis and network meta-analysis of randomised controlled trials 2017 to 2021

 

Relative risk (RR)

95% confidence interval

Main analysis

 LDCT vs. usual care

0.86

0.75 to 0.98

 LDCT vs. CXR

0.85

0.73 to 0.99

 CXR vs. usual care

1.01

0.87 to 1.17

Sensitivity analysis

 LDCT vs. usual care

0.85

0.76 to 0.97

 LDCT vs. CXR

0.86

0.75 to 0.98

 CXR vs. usual care

0.99

0.89 to 1.12

Back to article page

Diagnostic and Prognostic Research

ISSN: 2397-7523

Contact us